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http:WHAT THIS PAPER ADDS
Endovascular treatment seems to be a potential option in patients with type A dissection at prohibitive risk for
open surgery. At the moment there are only few reports in the literature and the technique is not standardised.
This article underlines a preoperative study method and an operative technique. We hope it may be useful for
surgeons approaching this new endovascular frontier.Background: Open repair is the gold standard for type A aortic dissection (TAAD). Endovascular option has been
proposed in very limited and selected TAAD patients. We report our experience with endovascular TAAD repair.
Methods: Inclusion criteria were: (1) entry tear in the ascending aorta; (2) proximal landing zone of at least 2 cm;
(3) distance between entry tear and brachio-cephalic trunk of at least 0.5 cm; (4) no signs of cardiac tamponade
or severe aortic regurgitation and (5) no signs of aortic branches ischaemia. Patients with cardiac
revascularisation from ascending aorta were excluded.
Results: From April 2009 to June 2012, 37 patients with TAAD were admitted to our hospital. As many as 28
underwent surgical repair and 9 were considered at high surgical risk in a multidisciplinary meeting. Four met our
inclusion criteria for an endovascular approach. Two of them had previous ascending aortic repair for TAAD and
one had aortic valve replacement. Technical success was achieved in 100% of the patients. No mortality was
registered during a median follow-up of 15 months (range 4e39 months), no migration of the graft and complete
false lumen thrombosis of the ascending aorta in three patients.
Conclusion: Endovascular treatment of TAAD is challenging but feasible in a selected subset of patients. Further
research remains mandatory.
 2013 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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catastrophe associated with high mortality. Medical treat-
ment is associated to poor outcome with a mortality rate
around 60%.1,2 Open surgical repair is the standard treat-
ment for TAAD despite a high mortality/morbidity rate
especially in high-risk patients, reported up to 60%.3,4
Because mortality is strongly related to both preoperative
conditions of these patients and the invasiveness of the
interventions, a less invasive approach would be highly
beneﬁcial.
Over the last decades endovascular therapies have
emerged as the therapy of choice in patients with
descending thoracic and abdominal aortic diseases.5 The
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//dx.doi.org/10.1016/j.ejvs.2013.01.033have broadened the indications for these interventions,
and even diseases affecting the ascending aorta can be
treated. Primary reports focussed on retrograde type A
dissections affecting the aortic arch in which the primary
entry tear was located in the descending segment. These
patients were treated by stent graft placement in the
descending aorta.6 Currently, stent graft placement in the
ascending aorta for the treatment of aneurysms, pseudo-
aneurysms, penetrating ulcers, intramural haematoma
and even type A dissections has been described in anec-
dotical reports.7e9 Computed tomographic (CT) scan
imaging studies show that endovascular repair is anatomi-
cally feasible in about 30% of patients with type A dissec-
tion with a proximal entry tear in the ascending aorta. This
percentage of patients may increase up to 39% with the
use of extra-anatomic bypass, like a left to right carotide
carotid bypass, in order to obtain an adequate distal
landing zone.10,11
In this study we present our initial experience with
endovascular repair for TAAD patients by placement of
a stent graft in the ascending aorta.
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Patient selection
Patients admitted to our institution with TAAD were eval-
uated by cardiac surgeons. Those considered at high risk for
open ascending aortic repair and suitable for endovascular
repair underwent a stent graft placement in the ascending
aorta through an open femoral artery access. Inclusion
criteria were: (1) entry tear in the ascending aorta; (2)
distance between sinotubular junction and entry tear of at
least 2 cm; (3) distance between entry tear and brachio-
cephalic trunk of at least 0.5 cm; (4) no signs of cardiac
tamponade or severe aortic regurgitation; (5) no signs of
ischaemia of aortic branches and (6) adequate femoral and
iliac arteries. Patients with cardiac revascularisation from
ascending aorta were excluded.
The option of stent graft placement was discussed with
the patient, too. The patient agreed to undergo this
procedure and written informed consent was obtained.Imaging
Computed tomography angiography (CTA) images were
acquired on multislice CT scan with a 0.625-mm detector
conﬁguration (manufacturer GE VCT 64 MD light speed,
General Electric, Little Chalfont, Buckinghamshire, UK). Non-
contrast images were ﬁrst obtained and followed by
acquisition of 1.25-mm axial images and retro-
reconstruction at 0.625 mm from the origin of carotid
arteries to the femoral arteries after intravenous injection
of 80e90 ml of non-ionic contrast (400 mg ml1). Subse-
quently, the acquired CTA data sets were transferred to
a workstation (OsiriX 3.9.4 e 64 bit) for analysis. A central
lumen line was generated and the distance between the
entry tear and the sinotubular junction and innominate
artery were measured (Fig. 1). Stent graft selection was
based on the aortic diameter measured at the level of the
entry tear, with at least 10% oversizing in respect to the
true lumen, but not exceeding the original aortic diameter.
We performed a 20% of oversizing in case of previous
ascending aortic graft replacement (20% of oversizing with
respect to the graft diameter). The presence of pericardial
effusion and aortic regurgitation was investigated with the
use of trans-oesophageal echocardiography (TEE).Figure 1. Limited type A dissection. (A) Center line. (B) 3D VR
reconstruction. (C) 3 years Follow-up CT-scan: 3D VR
reconstruction.Procedure
All the procedures were performed under general anaes-
thesia, with a surgical femoral access. A guide wire was
introduced in three cases through a percutaneous right
brachial access into the arch and descending aorta as
a rescue for supra-aortic vessels. In one case a reversed left
common carotid (LCC) to right common carotid (RCC) and
right subclavian artery (RSA) bypass was performed to
obtain an adequate distal landing zone; an Amplatzer
vascular plug II e 22 mm (St. Jude Medical, Playmouth,
Minnesota, USA) was used to occlude the origin of the
brachio-cephalic trunk. Through the femoral artery a Land-
erquist stiff guide wire (COOK, Inc., Bloomington, IN, USA)
S. Ronchey et al. 477was positioned into the left ventricle. Under ﬂuoroscopic
guidance the graft was advanced into the ascending aorta.
We used a standard Cook Zenith TX2 in one case and an off-
the-shelf device for the ascending aorta (Cook, Inc., Bloo-
mington, IN, USA) in two patients. Before deployment of
the graft an angiography was performed to check for
additional entry tears and extension of the dissection.
Cardiac pacing (180 beats/min) was used to reach systolic
blood pressure up to 40e60 mmHg to prevent dislodge-
ment of the stent graft during deployment. Through a right
common femoral vein we placed a temporary ventricular
pacing wire in the apex of the right ventricle. TEE and
completion angiography were used to verify the compe-
tence of the aortic valve, check the patency of the coronary
arteries and supra-aortic branches and to evaluate the
exclusion of the dissection.
RESULTS
Between April 2009 and June 2012, 37 patients with TAAD
were submitted to the Emergency Department of our
hospital, at the cardiac surgery department. Nine of them
were considered at high risk for open surgery because of co-
morbidities and/or previous sternotomy. The anatomic
characteristics of these patients were studied for an endo-
vascular approach and four of them respected our inclusion
criteria and were addressed to a stent graft position in the
ascending aorta (two males: mean age 70 years; Table 1).
All patients were smokers and had hypertension; one
patient had atrial ﬁbrillation. One patient had prior aortic
valve repair and two patients had previous ascending aortic
repair for TAAD (in one of them the ascending aortic repair
was associated to the aortic valve replacement) with
a residual entry tear in the ascending aorta. The patients
with previous ascending aortic repair were ﬁrst treated with
analgesic and anti-hypertensive therapies without results.
Three patients were operated in acute setting (<8 h after
acute onset of symptoms), one of these because of brachio-
cephalic trunk symptomatic dissecting dilatation (32 mm,
no neurologic signs, neck pain not responding to medical
therapy) occurring 48 months after ascending aorta
replacement. In one case the procedure was delayed (48 h).
Mean operating time was 128 min (range 90e215 min). An
LCCeRCCeRSA bypass was performed in one case. Tech-
nical success was achieved in 100% of the patients, with
complete exclusion of the entry tear. Stent graft length
ranged between 55 and 81 mm and diameter between 35Table 1. Baseline characteristics.
Sex Age Co-morbidities
Patient 1 F 69 Hypertension, Tabaco use
Patient 2 M 58 Hypertension, Tabaco use, previ
aorta replacement for type A di
Patient 3 F 78 Hypertension, diabetes, dyslipid
aortic valve replacement (2011)
Patient 4 M 75 Hypertension, COPD, previous a
replacement (2008), ascending
replacement for type A dissectiand 40 mm. No death was registered during follow-up
(range 4e39 months, mean 15 months). One patient
experienced a pulmonary oedema 2 months after the
procedure, not operative related. Control CT scans
demonstrated no migration of the graft. A complete false
lumen thrombosis of the ascending aorta was obtained in
three patients, whereas in one case the false lumen in the
ascending aorta was still patent, without aortic enlarge-
ment. This patient remains asymptomatic at 9 months’
follow-up.
In two patients the complete false lumen thrombosis of
the descending thoracic aorta was obtained, whereas in the
other two patients only a partial false lumen thrombosis
was obtained (Tables 2 and 3).
DISCUSSION
With increasing aged population the incidence of TAAD is
rising, especially in the elderly group.12 In these patients
open surgical repair is indicated, with graft replacement of
the ascending aorta and, in the presence of aortic regurgi-
tation, with valve resuspension or replacement. It has been
reported that both preoperative clinical condition of the
patient and invasive character of such procedures are
associated with high mortality rates, ranging up to 60% in
octogenerians.2e4 Medical therapy alone has a comparable
or even worse outcome, and therefore less invasive treat-
ment options, such as endovascular therapies, might be
beneﬁcial.1,2 Our study conﬁrmed that, in a small selected
subset of patients, stent graft placement in the ascending
aorta for TAAD is feasible and may represent an effective
and safe procedure.
In 2000 Dorros et al. reported the ﬁrst case of TAAD
treated with an endovascular technique through a trans-
septal approach.13 Since then several authors have pub-
lished their experiences, but the current literature remains
sparse (Table 4). Ye et al. reported the largest series con-
sisting of 10 patients with only midterm follow-up.14 These
results seem promising if we consider the high-risk patients
and their poor prognosis.
As the landing zones are located very close to the coro-
nary and innominate arteries, stent graft placement in the
ascending aorta may be performed only in selected cases.
Two studies have been conducted to investigate the feasi-
bility of stent graft placement in type A dissections.10,11
Moon et al. showed that in 162 patients with TAAD 32%
were anatomically suitable for endovascular repair as thereASA/Euro-score Time between
symptoms and OR
III/9.42% <8 h
ous ascending
ssection (2007)
III/34.93% <8 h
emia, previous IIIeIV/37.05% <8 h
ortic valve
aorta
on (2012)
IIIeIV/34.38% 2 days
Table 2. Characteristics dissection and procedure.
Diameter
ascending
aorta
Number
of entry
tears
Distance
entry tear
LSCA
Distance
entry
tear STJ
Type of
stent
graft
Measurements
stent graft
Length of
procedure
(min)
Technical
success
Additional
procedure
In-hospital
mortality
In-hospital
morbidity
Patient 1 36 1 60 24 Cook TX2 40e31 90 Yes No No No
Patient 2 32 1 30 45 OS Cook 38e73 215 Yes Yesa No No
Patient 3 36 1 84 15 OS Cook
OS Cook
38e55
38e55
170 Yes No No No
Patient 4 40 1 46 36 OS Cook 42e72 140 Yes No No no
LSCA: left subclavian artery, STJ: sinotubular junction, AT: anonymous trunk, OS: off the shelf.
a LCCAeRCCAeRSA bypass þ AT embolisation.
Table 3. Follow-up.
Length of FU
(months)
Thrombosis FL
ascending AO
Thrombosis FL
descending AO
Ascending aortic
diameter
Complications Additional
procedures
Mortality
Patient 1 39 Yes Yes 34 No No No
Patient 2 15 Yes Yes 30 No No No
Patient 3 9 No Partial 36 No No No
Patient 4 4 Yes Partial 34 No No No
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length and diameter of proximal sealing zones.10 Hybrid
procedures could be used to extend the applicability by
combining a supra-aortic debranching procedure with
endovascular stent graft placement. We performed this in
one patient (Fig. 2). The use of a left-to-right carotid bypass
can increase the feasibility of endovascular treatment of the
ascending aorta up to 40% of all TAAD patients.11
A thorough understanding of the anatomical limits of the
aortic dissection and the adjacent anatomy is a prerequisite
before such procedures are performed. Identiﬁcation of the
primary entry tear is essential for the success of stent
grafting, although this may be a difﬁcult process. The
development of multi-detector-slice CT scanners and post-
processing software has resulted in superior imaging with
less artefacts, improving the sensitivity and speciﬁcity of
this imaging modality.15,16 Three-dimensional reconstruc-
tions and virtual endoluminal imaging can be useful toTable 4. Review of literature.
First author Year Stentgraft Number of
patients
Acute (%)
Dorros et al. 2000 Lacteba 1 1(100)
Kato et al. 2001 Home-made 7
Wang et al. 2003 COV Z-STENT 1 1(100)
Ihnken et al. 2004 GENERIC BARE,
GORE
1 1(100)
Zhang et al. 2004 GIANTURCO Z 1 0(0)
Rayan et al. 2004 GORE
Verhoye et al. 2006 COOK-Z 1 1(100)
Zimpfer et al. 2006 JOTEC 1 1(100)
Senay et al. 2007 GORE TAG 1 1(100)
Mussa et al. 2007 GORE TAG 1
Palma et al. 2008 BRAILE BIOMED 1 0(0)
Kische et al. 2008 COOK 2
Nienaber et al. 2011 VARIOUS 6
Ye et al. 2011 VARIOUS 10 6(60%)
Metcalfe et al. 2012 Cook 1 1(100)assess the size and location of the intimal tear and to
determine the precise length and diameter of the stent
graft for successful exclusion of the dissection.17 Other
radiologic ﬁndings, such as pericardial effusion, aortic
diameter, the diameters of true and false lumen and the
status of thrombosis of the false lumen, may be helpful in
planning the procedure.18
Endovascular procedures in TAAD patients harbour
considerable risks. The aortic arch manipulation with guide
wires and stent grafts can lead to extension of dissection or
dislodgement of thrombus. To avoid such complications, in
selected cases, a right carotid artery access for the stent
graft can be used. This is also associated with an increased
risk of stroke, so we preferred to perform all procedures
from a femoral route. Aortic valve insufﬁciency is another
important complication, which is associated with aortic
dilatation due to the stent graft. This complication might be
related to excessive oversizing.19 Based on this observation30-day
Mortality
(%)
Endoleak
(%)
CVA (%) Late
mortality
(%)
Prev.
interv
FU (m)
0(0) 0(0) 0(0) 0(0) e e
0 3e42
0(0) 0(0) 0(0) 0(0) e e
0(0) 0(0) 0(0) 0(0) 0 e
0(0) 0(0) 0(0) 0(0) 0 12
1(MPA) e e
0(0) 0(0) 0(0) 0(0) e e
0(0) 0(0) 0(0) 0(0) 0 0
0(0) 1(100) 0(0) 0(0) 0 0
1 1 0
0(0) 0(0) 0(0) 0(0) e e
e e
0 9e39
1(10) 1(10) 2(20) 10 0 35.5
0(0) 0(0) 0(0) 0(0) e e
Figure 2. (A) Type A dissection after limited open repair estended
to brachio-cephalic trunk and right common carotid artery: 3D VR
reconstruction. (B) TEVAR in the ascending aorta þ reversed LCCe
RCCeRSA bypass. Plug into the brachio-cephalic trunk: 3D VR
reconstruction.
Figure 3. Cook off-the-shelf device for ascending.
S. Ronchey et al. 479we adopted a maximum oversizing of 10%. A complete TEE
should be performed in all cases to assess cardiac and aortic
valve function, in combination with an angiography to
conﬁrm the patency of the supra-aortic branches and
coronary arteries.
Development of novel devices and techniques and
increasing experience in these types of procedures are
fundamental, before these techniques can be widely
adopted. In our experience we used in three cases a device
speciﬁcally designed from Cook for the ascending aorta,
with a longer shaft (100 cm) and a short tip (2 cm) (Fig. 3).
Recently Metcalfe et al. published their experience with the
implementation of a stent in a TAAD patient, designed
speciﬁcally for ascending aorta, consisting of a 65-mm
covered component and proximal and distal bare stents.20
Although the use of bare stents in aortic dissectionsremains highly debated, as it may induce a new dissection
or a re-entry tear, the results of these developments, in
combination with other studies, are eagerly awaited.21,22
Our experience is limited to a small, atypical, number of
patients with TAAD. Three of them had previous cardiac
surgery. In these patients the natural risk of retrograde
dissection, cardiac tamponade or aortic rupture was lower.
A re-intervention was necessary because of the medical
therapy failure, but open surgery was considered at high
risk by a multidisciplinary team at our institute.
Again, previous ascending aortic replacement is another
bias of this group of patients because it certainly eliminates
the risk of retrograde dissection during TEVAR. However,
the presence of a mechanical aortic valve made the
procedure more technically demanding.
We propose endovascular treatment of the ascending
aorta in a very selected number of cases and still consider
open repair the gold standard.CONCLUSION
Endovascular treatment of TAAD by placement of a stent
graft in the ascending aorta is a challenging procedure due to
the proximity of the aortic arch branches and coronary
arteries. Our experience shows that this technique is feasible
in selected patient categories, and it seems associated with
480 European Journal of Vascular and Endovascular Surgery Volume 45 Issue 5 May/2013favourable results. Before this therapy can be implemented in
the daily practice, further research is mandatory.
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